paroxetine has been researched along with Dyskinesia, Drug-Induced in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishop, C; Conti, MM; Dell'isola, R; Goldenberg, AA; Kampton, E; Katzman, AC; Lindenbach, D; Ostock, CY | 1 |
| Bishop, C; Buchta, W; Dickinson, SO; Eissa, S; Eskow Jaunarajs, KL; George, JA; Goldenberg, AA; Mohamed, M | 1 |
| Coffey, DB; John, N; Potter, PO | 1 |
| König, F; Raape, J; Truöl, S; Von Hippel, C | 1 |
| al-Adwani, A | 1 |
| Bristow, LJ; Cunningham, JR; Hogg, JE; Hutson, PH; Longmore, J; Murray, F; Pearce, D; Razzaque, Z; Saywell, K; Tricklebank, MD | 1 |
| Botsaris, SD; Sypek, JM | 1 |
| Leo, RJ | 1 |
| Abraham, JT; Brown, R; Meltzer, HY | 1 |
| Friedman, JH | 1 |
| Begley, AE; Mamo, DC; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF; Stack, JA; Sweet, RA | 1 |
| Lee, MS; Nam, JW | 1 |
1 review(s) available for paroxetine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Movement disorders associated with the serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Age Factors; Aged; Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, Drug-Induced; Dystonia; Female; Fluoxetine; Fluvoxamine; Humans; Male; MEDLINE; Middle Aged; Parkinson Disease, Secondary; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 1996 |
1 trial(s) available for paroxetine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients.
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2000 |
10 other study(ies) available for paroxetine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.
Topics: Animals; Citalopram; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2014 |
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Biogenic Monoamines; Citalopram; Corpus Striatum; Dyskinesia, Drug-Induced; Fluoxetine; Levodopa; Male; Parkinsonian Disorders; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2012 |
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.
Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment | 2012 |
[Improvement of tardive dyskinesia after treatment with olanzapine].
Topics: Affective Disorders, Psychotic; Aged; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Neurologic Examination; Olanzapine; Paroxetine; Patient Admission; Pirenzepine | 2002 |
Brain damage and tardive dyskinesia.
Topics: Adult; Brain Damage, Chronic; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1995 |
The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea pig.
Topics: Animals; Biogenic Monoamines; Brain; Dyskinesia, Drug-Induced; Electric Stimulation; Fluoxetine; Guinea Pigs; Humans; In Vitro Techniques; Male; Methiothepin; Oxadiazoles; Paroxetine; Piperazines; Raphe Nuclei; Serotonin Antagonists; Synaptic Transmission; Tryptophan | 1995 |
Paroxetine and tardive dyskinesia.
Topics: Aged; Aged, 80 and over; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1996 |
Clozapine treatment of persistent paroxysmal dyskinesia associated with concomitant paroxetine and sumatriptan use.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bipolar Disorder; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Neurologic Examination; Paroxetine; Serotonin Receptor Agonists; Sumatriptan | 1997 |
Rapid onset tardive dyskinesia ("fly catcher tongue") in a neuroleptically naive patient induced by risperidone.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Mastication; Paranoid Disorders; Paroxetine; Risperidone; Tongue | 1998 |
A case of paroxetine-induced dyskinetic movements.
Topics: Aged; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2000 |